Earlier today Summit Therapeutics announced the results of the PhaseOut DMD clinical trial of Ezutromid. Although Ezutromid was safe and well …
Summit announces results of PhaseOut DMD clinical trial of EzutromidRead More
ReveraGen BioPharma announces preliminary results of Vamorolone trial
ReveraGen BioPharma has announced encouraging preliminary results of their early stage clinical trial of Vamorolone, a potential drug that researchers …
ReveraGen BioPharma announces preliminary results of Vamorolone trialRead More
HELLO FROM YOUR NEW ACTION DUCHENNE TEAM!
We would like to start the week by saying hello and introducing ourselves as your new Action Duchenne team! We are dedicated in delivering our vision …
Santhera announces renewal of Raxone EAMS
Santhera has announced that the MHRA (the UK’s drug and medicines regulator) has granted a renewal of the Early Access to Medicines Scheme scientific …
CEO attends EURORDIS Summer School
Last week our incoming CEO, Shelley Simmonds, completed a 5 day intensive training programme in Barcelona, having been selected to take part in the …
Sarepta announce early, preliminary gene therapy trial results
Sarepta therapeutics has announced preliminary results of a gene therapy trial that is using a harmless virus to deliver a small but functional …
Sarepta announce early, preliminary gene therapy trial resultsRead More
DMD Pathfinders launch new nutrition guide for adults
DMD Pathfinders have worked with global health professionals to create a guide which provides information on nutrition for adults with Duchenne. They …
DMD Pathfinders launch new nutrition guide for adultsRead More
Solid Biosciences announce FDA have removed clinical hold from their gene therapy trial
Solid Biosciences have announced that the FDA has given approval for the company to restart the phase I/II IGNITE DMD clinical trial. The clinical …
Solid Biosciences announce FDA have removed clinical hold from their gene therapy trialRead More
Career Legal Bake Off is a great success!
Thank you to the wonderful Abbie Smith and Michelle McDermott of Career Legal for organising the fantastic Bake Off on Friday 8 June for Action …
New technology could highlight potential treatments for Duchenne muscular dystrophy
Researchers from Queen Mary University of London have developed new cell-based technologies which could improve understanding of the muscle-wasting …
New technology could highlight potential treatments for Duchenne muscular dystrophyRead More
Action Duchenne represent our community at bone protective therapy ENMC workshop
Bone Protective Therapy in Duchenne MD Date: 2018-06-03 Number: 236 City: Hoofddorp, The Netherlands Description: 236th ENMC …
Action Duchenne represent our community at bone protective therapy ENMC workshopRead More
Take part in ventilator study and earn £75
SuAzio are currently conducting a study and are looking for individuals who live with Duchenne, or their caregivers to be part of this study. …
